Calidi Readies SPAC Merger
BIOTECH: Estimated Proceeds Up to $82M
■ By JEFF CLEMETSON
Calidi Biotherapeutics, Inc. will soon be getting a ticker on the NYSE.
The company is currently preparing for a merger with special purpose acquisition company First Light Acquisition Group (FLAG) and expects to be trading on the NYSE American...
Read latest San Diego Business Journal online.